Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia

Journal of Cardiovascular Pharmacology
Ning ZhouJie-Fang Bian

Abstract

Intimal hyperplasia (IH) exerts a critical role in vein graft failure after arterial bypassing. Insulin has been demonstrated to remarkably decrease IH in the rat carotid injury model. We hypothesized that postoperative insulin medication prevents the autologous vein graft from IH. Dogs were subjected to jugular-carotid interposition bypass grafting and intravenously infused with vehicle, glucose-insulin-potassium, glucose-potassium, or glucose-insulin-potassium plus Wortmannin 5 minutes before and 4 hours after reperfusion. Then vein grafts were harvested for caspase-3 activation, cell apoptosis, phosphorylated Akt, and endothelial nitric oxide synthase level assays. Other dogs undergoing the same operation were administered with subcutaneous injection of 4 U insulin or 0.5 mL saline two times per day for 1 month postoperatively. Vein grafts were sampled to assess cell proliferation, intimal/medial thickness, and expression of endothelial nitric oxide synthase and [alpha]-smooth muscle actin. Glucose-potassium aggravated apoptosis and caspase-3 activation and decreased Akt and endothelial nitric oxide synthase phosphorylation; however, glucose-insulin-potassium significantly inhibited cell apoptosis and caspase-3 activation an...Continue Reading

References

May 22, 1998·The Annals of Thoracic Surgery·J E O'BrienJ D Mannion
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·C HermannS Dimmeler
Nov 18, 2000·The Annals of Thoracic Surgery·E RodriguezJ D Mannion
Aug 15, 2002·American Journal of Physiology. Cell Physiology·Asha JacobNajma Begum
Sep 3, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Manuel MayrQingbo Xu
Jun 6, 2003·The New England Journal of Medicine·David M NathanUNKNOWN Epidemiology of Diabetes Interventions and Complications Research Group
Dec 20, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Satu Vehkavaara, Hannele Yki-Järvinen
Jan 20, 2004·Heart·N L WalkerD H Birnie
Jun 16, 2004·Circulation·Nicola FransciniGabriele Schoedon
Feb 1, 2005·The Annals of Thoracic Surgery·Joseph F SabikDelos M Cosgrove
Jul 9, 2005·Critical Care Medicine·Matthias TurinaHiram C Polk
Sep 13, 2005·Journal of Vascular Research·Tony KimAdria Giacca
Oct 11, 2005·Apoptosis : an International Journal on Programmed Cell Death·Q FanX L Ma
May 24, 2007·American Journal of Physiology. Endocrinology and Metabolism·Hui SuFeng Gao
Oct 19, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Mary Y K LeePaul M Vanhoutte
May 2, 2008·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Norbert ZimmermannThomas Hohlfeld
May 7, 2008·The Journal of Biological Chemistry·David AllardTrevor D Littlewood
Oct 18, 2008·Clinics·Ayumi Aurea MiyakawaJose Eduardo Krieger
Feb 21, 2009·Journal of the American College of Cardiology·Paresh DandonaPriya Mohanty
Feb 24, 2009·Journal of Vascular Surgery·Akio KodamaTakeo Itoh
Feb 24, 2009·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·E R IsenovicP Marche
Oct 27, 2009·Apoptosis : an International Journal on Programmed Cell Death·Paul A J KrijnenHans W M Niessen

❮ Previous
Next ❯

Citations

Dec 3, 2013·Canadian Journal of Physiology and Pharmacology·Simon ChiangAdria Giacca
Sep 29, 2017·Journal of Cardiovascular Pharmacology and Therapeutics·Lingling OuWenqi Dong

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.